Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Techstars
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Ring Therapeutics51-200 employees • 2 roles
Ring Therapeutics is a biotechnology company creating novel vector conjugate medicines that carry more and reach further, expanding…
CytosolixVenture round $6.6M · 3 yr ago • 11-50 employees
Our Tumor Activated Permeability (TAP) Platform produces weakly-acidic derivatives of known oncology drugs that already work. It preserves…
EngitixVenture round · 1 mo ago • Founded 2016 • 51-200 employees • 3 roles
We are decoding the role of the extracellular matrix (ECM) in health and disease to discover new drug targets, biomarkers, and novel…
3T BiosciencesFounded 2017 • 51-200 employees
We are solving a major bottleneck in the field of targeted biotherapeutics in oncology – the identification of novel targets for the…
SystImmuneConvertible Note $7.2M · 2 yr ago • Founded 2022 • 201-500 employees • 40 roles
Focused on oncology, we are committed to continuously innovating and developing new breakthrough cancer drugs, aiding cancer patients to…
Abinitio bio is the AI-native operating platform for drug development and manufacturing.

Overview

Team Oncology drug development meets computational cancer biology Many oncology targets fail in the clinic because preclinical models reflect human disease poorly. We built Gordion to close that gap: patient-derived data analyzed by people who have taken drugs into the clinic.

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
2
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Poznań Poland
HQ
Cambridge United States
Regional office
Gordion Bioscience Inc.
Cambridge, MA 02142, US
company site